Hodgkin lymphoma cell lines: to separate the wheat from the chaff

2018 ◽  
Vol 399 (6) ◽  
pp. 511-523 ◽  
Author(s):  
Hans G. Drexler ◽  
Claudia Pommerenke ◽  
Sonja Eberth ◽  
Stefan Nagel

Abstract Characteristic components of Hodgkin lymphoma (HL) tissue are the mono- or multinucleated Hodgkin-Reed-Sternberg (HRS) cells. Given the challenges of isolating these rare malignant cells and the difficulty in culturing cells from patients, many investigators have tried to establish cell lines in efforts to develop cellular tools for in vitro studies. A limited number of HL cell lines exist and have provided valuable insights into HL pathobiology. A literature survey indicated that 35 cell lines derived from HL patients have been published. To determine whether all these alleged HL cell lines hold up to scrutiny, we examined the available data and also put some of these cell lines to the test of hierarchical clustering, providing additional information regarding assignment to cell line type and tissue derivation. Hierarchical clustering separated the bona fide (classical) HL cell lines completely from cell lines derived from other lymphoma categories and proved conclusively that HL cell lines represent a distinct entity, irrespective of the cellular origin of the HRS cells. We conclude by pointing out the need for an intensified search for new cell culture avenues in order to develop a new generation of informative HL cell lines covering more widely the spectrum of HL stages and subtypes.

Author(s):  
A Ustaszewski ◽  
J Paczkowska ◽  
J Janiszewska ◽  
S Hartmann ◽  
J Bein ◽  
...  

2010 ◽  
Vol 177 (6) ◽  
pp. 3081-3088 ◽  
Author(s):  
Jun-ichiro Ikeda ◽  
Suhana Mamat ◽  
Tian Tian ◽  
Yi Wang ◽  
Nur Rahadiani ◽  
...  

2011 ◽  
Vol 39 (8) ◽  
pp. 850-858 ◽  
Author(s):  
Ingrid Glimelius ◽  
Jenny Rubin ◽  
Marie Fischer ◽  
Daniel Molin ◽  
Rose-Marie Amini ◽  
...  

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 1922-1922
Author(s):  
Joost Kluiver ◽  
Eugenia Haralambieva ◽  
Debora de Jong ◽  
Tjasso Blokzijl ◽  
Susan Jacobs ◽  
...  

Abstract We previously demonstrated a high expression of primary-microRNA BIC (pri-miRNA-155) in Hodgkin lymphoma (HL) and lack of expression in most non-Hodgkin lymphoma subtypes including some Burkitt lymphoma (BL) cases. Recently, a high expression of BIC was reported in BL in comparison to pediatric leukemia and normal peripheral blood samples. In this study we extended our series of BL cases and cell lines for BIC expression by RNA in-situ hybridization (ISH) and quantitative (q)RT-PCR. Both BIC RNA-ISH and qRT-PCR revealed no or only low levels of BIC in 25 BL tissues, including 7 Epstein-Barr virus (EBV) positive cases, compared to HL and normal controls. In agreement with these findings, Northern blotting revealed absence of miR-155 in BL tissues. EBV negative and EBV latency type I BL cell lines also showed very low BIC and miR-155 expression levels as compared to HL cell lines. Higher levels of BIC and miR-155 were detected in in vitro transformed lymphoblastoid EBV latency type III BL cell lines. An association of latency type III infection and induction of BIC was supported by consistent expression of BIC in 11 and miR-155 in 2 posttransplantation lymphoproliferative disorder (PTLD) cases. In summary, we demonstrated that expression of BIC and miR-155 is not a common finding in BL. Expression of BIC and miR-155 in 3 latency type III EBV positive BL cell lines and in all primary PTLD cases suggests a possible role for EBV latency type III specific proteins in the induction of BIC expression.


Blood ◽  
2005 ◽  
Vol 105 (9) ◽  
pp. 3707-3713 ◽  
Author(s):  
Mariko Kawakami ◽  
Koji Kawakami ◽  
Mitomu Kioi ◽  
Pamela Leland ◽  
Raj K. Puri

AbstractHodgkin lymphoma represents unique clinicopathologic features because Hodgkin and Reed-Sternberg (H-RS) cells produce a variety of cytokines, express a variety of cytokine receptors, and are surrounded by numerous nonmalignant immunoreactive cells. We found that receptors for interleukin-4 (IL-4R) are highly expressed in H-RS cells. To target interleukin-4 receptor (IL-4R), we used a recombinant protein fusing circularly permuted human IL-4 and Pseudomonas exotoxin termed IL438-37-PE38KDEL, or IL-4 cytotoxin. The cytotoxic effect of IL-4 cytotoxin on H-RS cell lines was determined to be moderate to high in vitro. We developed an infiltrating model of Hodgkin disease (HD) by injecting an adherent population of HD-MyZ cells subcutaneously into the flanks of beige/nude/X-linked immunodeficient mice. The animal model exhibited spontaneous metastasis of H-RS cells to lymph nodes and dissemination to vital organs, including the lungs. Intraperitoneal or intratumoral treatment of these mice with IL-4 cytotoxin resulted in regression of the primary tumor mass and a decrease in the incidence of lymph node metastasis. Mice injected with HD-MyZ cells demonstrated 203% prolonged survival (mean survival, 63 days) compared with control (mean survival, 31 days) when they received systemic IL-4 cytotoxin treatment. Because numerous H-RS cell lines express receptors for IL-4, IL-4 cytotoxin may be a unique agent for the treatment of Hodgkin lymphoma.


2008 ◽  
Vol 122 (4) ◽  
pp. 769-776 ◽  
Author(s):  
Donatella Aldinucci ◽  
Debora Lorenzon ◽  
Lara Cattaruzza ◽  
Antonio Pinto ◽  
Annunziata Gloghini ◽  
...  

2016 ◽  
Vol 12 (1) ◽  
pp. 219-232 ◽  
Author(s):  
D. Vergara ◽  
P. Simeone ◽  
S. De Matteis ◽  
S. Carloni ◽  
P. Lanuti ◽  
...  

Classical Hodgkin lymphoma models of T- and B-cell derivation show significant differences in their protein expression profiles.


Sign in / Sign up

Export Citation Format

Share Document